| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000004733 |
| Receipt No. | R000005637 |
| Official scientific title of the study | Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ) |
| Date of disclosure of the study information | 2010/12/16 |
| Last modified on | 2017/06/21 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ) | |
| Title of the study (Brief title) | Prospective cohort study on DAS of DRA patients in Japan (PCDJ) | |
| Region |
|
|
| Condition | |||
| Condition | Dialysis related amyloidosis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We will make the database of DRA to reveal the risk factors and the progress of DRA by prospective surveillance of radiographic imaging of cervical spine and lumbar spine in patients with DRA, including patient background, treatment protocol and so on. |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (1)change in intervertebral height of cervical spine and lumbar spine
(2)change in clinical entity [stage and form] of DSA according to the method described by Maruo et al. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who correspond to all the following conditions
(1)Patients who have a medical history of carpal tunnel surgery or trigger finger surgery. (2)Patients who have been undergoing hemodialysis for ten years or more. (3)Patients who are diagnosed as suspected cases or definite cases for the tentative criteria of DRA described in the report of the research and surveillance group for amyloidosis in 2009 (Scientific Research Grant of MHLW, The Project for Conquering Refractory Diseases). |
|||
| Key exclusion criteria | (1)Patients who have a medical history of surgery for diseases in cervical spine of lumbar spine
(2)Patients who are complicated by Rheumatoid arthritis (3)Patients who were considrered as ineligible for this trial by the attending doctor |
|||
| Target sample size | 600 | |||
| Research contact person | |
| Name of lead principal investigator | Takeshi Nakanishi |
| Organization | Hyogo College of Medicine |
| Division name | Department of Internal Medicne, Division of Kidney and Dialysis |
| Address | 1-1 Mukogawa-cho Nishinomiya, Hyogo |
| TEL | 0798-45-6521 |
| kuragano@hyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahiro Kuragano |
| Organization | Hyogo College of Medicine |
| Division name | Department of Internal Medicne, Division of Kidney and Dialysis |
| Address | 1-1 Mukogawa-cho Nishinomiya, Hyogo |
| TEL | 0798-45-6521 |
| Homepage URL | |
| betamacl25@yahoo.co.jp | |
| Sponsor | |
| Institute | beta2-microgloblin removal therapy study group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | beta2-microgloblin removal therapy study group |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | prospective cohort study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005637 |